Oral Topotecan Versus Intravenous Docetaxel In Pretreated, Advanced Non-Small Cell Lung Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to collect information on how effective and how well tolerated
an oral investigational drug is compared to a standard intravenous drug in patients with
pretreated, advanced non-small lung cancer (NSCLC).